Will DGCI ban on drug ingredients from China hurt the Pharma industry?

Mint 2018-02-16

Views 1

The ban on the import of APIs from China may lead to possible shortages of antibiotics, and anti-
diabetes, anti-psychotic and antacid drugs, say pharma lobby groups
Subscribe Now For Latest Updates- https://tinyurl.com/lbw8nze
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Some Unique Ingredients
play
02:56

Some Unique Ingredients
Pharma industry to post 15% growth in profit
play
03:12

Pharma industry to post 15% growth in profit
Reporter's Notebook | Sun Pharma eyes Swedish drug maker Meda
play
02:15

Reporter's Notebook | Sun Pharma eyes Swedish drug maker Meda
Note ban hits Rs20 trillion trafficking industry
play
00:49

Note ban hits Rs20 trillion trafficking industry
NGT bans ‘Chinese manjha’ for kite-flying
play
03:06

NGT bans ‘Chinese manjha’ for kite-flying
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
play
00:00

Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
play
00:00

Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
Digitalist Forum with MINT & SAP
play
00:00

Digitalist Forum with MINT & SAP
Transformation Agenda 2020 : India's changing urban landscape
play
00:00

Transformation Agenda 2020 : India's changing urban landscape
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
play
03:14

Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
Closing Bell
play
02:23

Closing Bell
Deals Space
play
03:09

Deals Space